Discover 3,507 paid clinical trials in Santa Monica, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,507
Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
for
Small Cell Lung Cancer
Location: Los Angeles CA, Fullerton CA, San Francisco CA,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06203210
Phase 3, Recruiting
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
for
Ovarian Neoplasms, Fallopian Tube Neoplasms,
Location: Los Angeles CA, Burbank CA, Duarte CA, Irvine CA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07213804
Phase 3, Recruiting
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Los Angeles CA, Los Alamitos CA, Irvine CA, La Jolla CA,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06973187
Phase 3, Recruiting
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
for
Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Location: Los Angeles CA, Newport Beach CA, Irvine CA, Orange CA,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT06793215
Phase 3, Recruiting
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
for
CLL, Chronic Lymphocytic Leukemia, SLL
Location: Los Angeles CA, Whittier CA, San Diego CA, Eugene OR,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06846671
Phase 3, Recruiting
A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
for
Atherosclerosis
Location: Los Angeles CA, Beverly Hills CA, West Hills CA,
Sponsor: Genentech, Inc.
Sex: All
Age: 18+
Code: NCT07448038
Phase 2, Recruiting
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
for
Oncology, MEK Mutation, RAF Gene Mutation,
Location: Westwood, Los Angeles CA, San Francisco CA, Houston TX,
Sponsor: Nested Therapeutics, Inc
Sex: All
Age: 18+
Code: NCT06326411
Phase 1, Recruiting
QTX3034 in Patients With KRAS G12D Mutation
for
Solid Tumors
Location: Los Angeles CA, Salt Lake City UT, Denver CO,
Sponsor: Quanta Therapeutics
Sex: All
Age: 18+
Code: NCT06227377
Phase 1, Recruiting
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
for
Hormone Receptor Positive HER-2 Negative Breast Cancer,
Location: Los Angeles CA, Beverly Hills CA, Fountain Valley CA,
Sponsor: Puma Biotechnology, Inc.
Sex: All
Age: 18+
Code: NCT06369285
Phase 2, Recruiting
A Study of APG-2575 in Combination With Azacitidine in Patients With Acute Myeloid Leukemia (AML)
for
AML, Adult
Location: Los Angeles CA, Seattle WA, Houston TX, Charlotte NC,
Sponsor: Ascentage Pharma Group Inc.
Sex: All
Age: 18 - 70+
Code: NCT04964518
Phase 1, Phase 2, Recruiting
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
for
Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis,
Location: Los Angeles CA, Torrance CA, La Jolla CA, San Diego CA,
Sponsor: Kartos Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06479135
Phase 3, Recruiting
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Los Angeles CA, San Francisco CA, Gilbert AZ,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company